Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 375 of 2529 entries
View as:

Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01433458 Org: User:
Start: 07/31/11 End: 12/31/11 Due: 12/31/12

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

Phase: N/A Priority: Normal
NCT ID: NCT00878072 Org: User:
Start: 03/25/09 End: 06/02/10 Due: 06/02/11

EPO906 in Carcinoid and Other Neuroendocrine Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00050349 Org: User:
Start: 07/31/02 End: 04/30/07 Due: 04/30/08

Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

Phase: N/A Priority: Normal
NCT ID: NCT01095250 Org: User:
Start: 04/30/10 End: 10/31/10 Due: 10/31/11

Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01915849 Org: User:
Start: 07/31/13 End: 01/31/14 Due: 01/31/15

Indacaterol 75 μg Compared to Placebo, Assessing Time to Patient's Perception of Onset of Effect in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01543828 Org: User:
Start: 01/31/12 End: 03/31/12 Due: 03/31/13

Safety and Pharmacokinetics of ASA404 When Given Together With Fluvoxamine, a Selective Serotonin Receptor Reuptake Inhibitor and CYP1A2 Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01299415 Org: User:
Start: 08/31/09 End: - Due: -

Study of the Safety, Tolerability, and Pharmacokinetics of LHW090 in Patients With Moderately Impaired Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT02678000 Org: User:
Start: 03/10/17 End: 10/11/18 Due: 10/11/19

CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT05168748 Org: User:
Start: 01/24/23 End: 08/13/26 Due: 08/13/27

Atrasentan in Patients With Proteinuric Glomerular Diseases

Phase: N/A Priority: Normal
NCT ID: NCT04573920 Org: User:
Start: 03/15/21 End: 10/27/26 Due: 10/27/27

Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04544189 Org: User:
Start: 01/20/21 End: 03/02/26 Due: 03/02/27

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02089087 Org: User:
Start: 01/07/13 End: 02/03/17 Due: 02/03/18

Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT00419159 Org: User:
Start: 12/31/06 End: 03/31/09 Due: 03/31/10

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Phase: N/A Priority: Normal
NCT ID: NCT03944707 Org: User:
Start: 07/18/19 End: 04/27/20 Due: 04/27/21

Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT03379727 Org: User:
Start: 02/13/18 End: 07/09/21 Due: 07/09/22

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT04544202 Org: User:
Start: - End: - Due: -

Safety Study of LBH589 When Given in Combination With Bortezomib in Adult Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00532389 Org: User:
Start: 10/31/07 End: 10/31/13 Due: 10/31/14

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00434174 Org: User:
Start: 12/31/06 End: 12/31/10 Due: 12/31/11

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

Phase: N/A Priority: Normal
NCT ID: NCT04933552 Org: User:
Start: 12/15/21 End: 05/31/32 Due: 05/31/33

A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT06551519 Org: User:
Start: 10/23/24 End: 09/16/27 Due: 09/16/28

Intra-venous Zoledronic Acid Once Yearly

Phase: N/A Priority: Normal
NCT ID: NCT00984893 Org: User:
Start: 11/30/08 End: 04/30/14 Due: 04/30/15

1 Year Open-label Extension to CZOL446H2337 Safety and Efficacy Trial of Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids

Phase: N/A Priority: Normal
NCT ID: NCT01197300 Org: User:
Start: 10/25/10 End: 02/27/19 Due: 02/27/20

Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06142357 Org: User:
Start: 12/29/23 End: 07/31/27 Due: 07/31/28

Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU

Phase: N/A Priority: Normal
NCT ID: NCT02477332 Org: User:
Start: 07/15/15 End: 06/12/17 Due: 06/12/18

The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00523549 Org: User:
Start: 11/30/06 End: 01/31/08 Due: 01/31/09